A cutting-edge platform developed by Assistant Professor Quanyin Hu uses protein-degrading platelets to suppress tumor regrowth and bolster immune response after surgery.

A cutting-edge platform developed by Assistant Professor Quanyin Hu uses protein-degrading platelets to suppress tumor regrowth and bolster immune response after surgery.
Professor Weiping Tang creates a new type of molecule to tag proteins on the surface of cancer cells for degradation.
Alum Joe Su (PhD ’08) aims to tame the ‘Wild West’ of natural products to tackle chronic inflammation.
Alumna Heidi Mansour (BS ‘96, PhD ’03), member of the National Academy of Inventors, aims to revolutionize lung and brain drug delivery.
PharmTox students pursue original, impactful research with Hilldale Undergraduate/Faculty and Sophomore Research Fellowships.
A newly developed nanomaterial that mimics the behavior of proteins could be an effective tool for treating Alzheimer’s and other neurodegenerative diseases.
Professor Seungpyo Hong continues to advance technology to track circulating tumor cells, which could lead to a more effective, easier way to monitor cancer progression.
Assistant Professor Ting Fu and collaborators have identified a promising new target for treatments that could help the millions of people worldwide who suffer from inflammatory bowel disease and related colorectal cancers.
Armed with two new grants, School of Pharmacy Assistant Professor Jason Peters continues his quest to find new targets for the hardest-to-treat bacterial infections.
New research by School of Pharmacy Professor Lingjun Li uncovers the role of neuropeptides in post-traumatic stress disorder.